Therapeutic Strategies to Overcome ALK Resistance in Cancer
Book Details
Format
Hardback or Cased Book
Book Series
Cancer Sensitizing Agents for Chemotherapy
ISBN-10
012821774X
ISBN-13
9780128217740
Publisher
Elsevier Science Publishing Co Inc
Imprint
Academic Press Inc
Country of Manufacture
NL
Country of Publication
GB
Publication Date
Jan 14th, 2021
Print length
216 Pages
Weight
590 grams
Dimensions
24.20 x 26.60 x 1.80 cms
Product Classification:
OncologyRespiratory medicine
Ksh 24,300.00
Manufactured on Demand
Delivery in 29 days
Delivery Location
Delivery fee: Select location
Delivery in 29 days
Secure
Quality
Fast
Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients with ALK-driven cancer are sensitive to tyrosine kinase inhibitor (TKI) therapy, but resistance invariably develops. This book discusses topics such as structure and function of ALK, ALK rearranged lung cancer, resistance mechanisms to ALK TKI tumors, and novel therapeutic strategies to enhance crizotinib anti-tumor efficacy in ALCL. Additionally, it encompasses information on drug combinations to enhance ALK TKI anti-tumor efficacy in neuroblastoma and future perspectives in the field. This book is a valuable resource for cancer researchers, clinicians and several members of biomedical field who need to understand more about how to fight ALK resistance in cancer treatment.
Get Therapeutic Strategies to Overcome ALK Resistance in Cancer by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by Elsevier Science Publishing Co Inc and it has pages.
